Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call for Investors07-08-2019
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call for InvestorsSuven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice of Board Meeting - Newspaper advertisementSuven Life Sciences Ltd - 530239 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Wednesday, The 14Th August, 2019
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Wednesday, the 14th August, 2019 at 11:00 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): ? To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended 30 June, 2019 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st July, 2019 as per PIT Code of the Company. Trading window will be opened from 19th August, 2019.SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding reminder to claim the dividends remaining unpaid/ unclaimed and transfer of unclaimed equity shares of the Company to the Investor Education and Protection Fund (IEPF) Suspense AccountSUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding Notice of the 30th Annual General Meeting, Book Closure and E-Voting InformationSUVEN LIFE SCIENCES LTD. - 530239 - Reg. 34 (1) Annual Report
Notice of the 30th Annual General Meeting (AGM) and Annual Report 2018-19SUVEN LIFE SCIENCES LTD. - 530239 - Notice Of The 30Th Annual General Meeting (AGM) And Annual Report 2018-19
With reference to the above subject, pursuant to Regulation 34 of the SEBI ((Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of the 30th AGM of the Members of the Company and the Annual Report for the financial year 2018-19. The same will also be hosted on the website of the Company at: http://www.suven.com/annualreports.aspx.SUVEN LIFE SCIENCES LTD. - 530239 - Shareholding for the Period Ended June 30, 2019
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click hereSUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 135342 Name of the Signatory :- K. HANUMANTHA RAODesignation :- Company Secretary and Compliance OfficerSUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
"Suven Life Sciences announces the delay in topline phase 2 study data of Masupirdine (SUVN-502)"